551 results on '"Beekman, Jeffrey M."'
Search Results
2. Elexacaftor/tezacaftor/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controls
3. Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis
4. Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study
5. Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
6. Readthrough compounds for nonsense mutations: bridging the translational gap
7. Targeted Locus Amplification and Haplotyping
8. Anticodon Engineered Transfer RNAs (ACE-tRNAs) are a Platform Technology for Suppressing Nonsense Mutations
9. Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation
10. A new era for people with cystic fibrosis
11. Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation
12. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations
13. CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
14. Colonization of vancomycin-resistant Enterococcus faecium in human-derived colonic epithelium: Unraveling the transcriptional dynamics of host-enterococcal interactions
15. Activating alternative chloride channels to treat CF: Friends or Foes?: Report on the Meeting of the Basic Science Working Group in Dubrovnik, Croatia
16. Colonization of vancomycin-resistant Enterococcus faecium in human-derived colonic epithelium: Unraveling the transcriptional dynamics of host-enterococcal interactions
17. Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis
18. OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion
19. Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids
20. R560S: A class II CFTR mutation that is not rescued by current modulators
21. Modulation of the maladaptive stress response to manage diseases of protein folding.
22. CFTR modulator theratyping: Current status, gaps and future directions
23. Cystic fibrosis: Beyond the airways. Report on the meeting of the basic science working group in Loutraki, Greece
24. Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity
25. Translational research to enable personalized treatment of cystic fibrosis
26. High-resolution 3D imaging of fixed and cleared organoids
27. Direct Interaction between FcγRI (CD64) and Periplakin Controls Receptor Endocytosis and Ligand Binding Capacity
28. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
29. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes
30. Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
31. Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping
32. Biobanking: towards increased access of biomaterials in cystic fibrosis. Report on the pre-conference meeting to the 13th ECFS Basic Science Conference, Pisa, 30 March-2 April, 2016
33. Current and future CFTR therapeutics
34. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
35. Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations
36. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
37. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes
38. Targeted Locus Amplification and Haplotyping
39. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
40. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes.
41. Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
42. Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
43. High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
44. Readthrough compounds for nonsense mutations: bridging the translational gap
45. Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
46. Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
47. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
48. Targeted Locus Amplification and Haplotyping
49. Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
50. Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.